M.V.I.-12 LYOPHILIZED Drug Patent Profile
✉ Email this page to a colleague
Which patents cover M.v.i.-12 Lyophilized, and when can generic versions of M.v.i.-12 Lyophilized launch?
M.v.i.-12 Lyophilized is a drug marketed by Teligent and is included in one NDA.
The generic ingredient in M.V.I.-12 LYOPHILIZED is ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine; riboflavin 5'-phosphate sodium; thiamine; vitamin a; vitamin e. There are six drug master file entries for this compound. Additional details are available on the ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine; riboflavin 5'-phosphate sodium; thiamine; vitamin a; vitamin e profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for M.V.I.-12 LYOPHILIZED?
- What are the global sales for M.V.I.-12 LYOPHILIZED?
- What is Average Wholesale Price for M.V.I.-12 LYOPHILIZED?
Summary for M.V.I.-12 LYOPHILIZED
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 126 |
| Clinical Trials: | 113 |
| Patent Applications: | 4,240 |
| DailyMed Link: | M.V.I.-12 LYOPHILIZED at DailyMed |
Recent Clinical Trials for M.V.I.-12 LYOPHILIZED
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Egyptian International Pharmaceutical Industries Co | PHASE4 |
| Suzhou Abogen Biosciences Co., Ltd. | PHASE2 |
| Abogen Biosciences (Shanghai) Co., Ltd | PHASE2 |
US Patents and Regulatory Information for M.V.I.-12 LYOPHILIZED
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teligent | M.V.I.-12 LYOPHILIZED | ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine; riboflavin 5'-phosphate sodium; thiamine; vitamin a; vitamin e | INJECTABLE;INJECTION | 018933-002 | Aug 8, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
